Improving Kaposi sarcoma care and research in Africa
Admin Core
['FUNDING_OTHER'] · LSU HEALTH SCIENCES CENTER · NIH-11415860
This program brings hospitals in the US, Zambia, and Tanzania together to improve diagnosis, care, and prevention of Kaposi sarcoma for people living with HIV.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LSU HEALTH SCIENCES CENTER (nih funded) |
| Locations | 1 site (NEW ORLEANS, UNITED STATES) |
| Trial ID | NIH-11415860 on ClinicalTrials.gov |
What this research studies
You and other patients will be seen at partner hospitals where clinicians will integrate Kaposi sarcoma (KS) checks into routine HIV care and collect blood and tissue samples. Labs will look for immune and metabolite signals linked to KS stage and response to treatment, and researchers will map where KSHV hides in tissues to find ways to stop it from reactivating. The program includes shared training and data-sharing between U.S. and African sites to build local capacity and improve clinical follow-up. Combining patient visits, lab tests, and coordinated care aims to speed up diagnosis and guide better prevention and treatment strategies.
Who could benefit from this research
Good fit: People living with HIV—particularly those with suspected or confirmed Kaposi sarcoma or at high risk for KS, and those receiving care at the participating centers in Zambia, Tanzania, or LSUHSC-New Orleans—are the main candidates.
Not a fit: People without HIV or those with cancers unrelated to Kaposi sarcoma or KSHV are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, the work could lead to earlier KS diagnosis, improved treatment decisions, and ways to prevent KS in people living with HIV.
How similar studies have performed: Integrated HIV-KS care programs have shown benefits in these settings, but the specific biomarker and viral-reservoir mapping work is relatively new and less tested.
Where this research is happening
NEW ORLEANS, UNITED STATES
- LSU HEALTH SCIENCES CENTER — NEW ORLEANS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WOOD, CHARLES — LSU HEALTH SCIENCES CENTER
- Study coordinator: WOOD, CHARLES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: AIDS associated cancer, AIDS related cancer, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Cancer Center